To test this hypothesis, we utilized HLA peptidomics to analyze the changes in the HLA peptide repertoire of melanoma cells due to PSMB8 and PSMB9 overexpression and determined the effects of these changes on the reactivity of patient infiltrating tumor lymphocytes (TILs). This evidence concerns the gene PSMB8 and melanoma.